CryoPort Shares Outstanding 2010-2024 | CYRX
CryoPort shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CryoPort Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
49 |
| 2023 |
49 |
| 2022 |
49 |
| 2021 |
46 |
| 2020 |
39 |
| 2019 |
33 |
| 2018 |
28 |
| 2017 |
23 |
| 2016 |
14 |
| 2016 |
7 |
| 2015 |
5 |
| 2014 |
0 |
| 2013 |
3 |
| 2012 |
2 |
| 2011 |
1 |
| 2010 |
0 |
| 2009 |
0 |
CryoPort Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-12-31 |
49 |
| 2024-09-30 |
49 |
| 2024-06-30 |
49 |
| 2024-03-31 |
49 |
| 2023-12-31 |
49 |
| 2023-09-30 |
49 |
| 2023-06-30 |
49 |
| 2023-03-31 |
48 |
| 2022-12-31 |
49 |
| 2022-09-30 |
49 |
| 2022-06-30 |
49 |
| 2022-03-31 |
50 |
| 2021-12-31 |
46 |
| 2021-09-30 |
46 |
| 2021-06-30 |
46 |
| 2021-03-31 |
44 |
| 2020-12-31 |
39 |
| 2020-09-30 |
39 |
| 2020-06-30 |
38 |
| 2020-03-31 |
38 |
| 2019-12-31 |
33 |
| 2019-09-30 |
36 |
| 2019-06-30 |
31 |
| 2019-03-31 |
30 |
| 2018-12-31 |
28 |
| 2018-09-30 |
29 |
| 2018-06-30 |
28 |
| 2018-03-31 |
27 |
| 2017-12-31 |
23 |
| 2017-09-30 |
25 |
| 2017-06-30 |
24 |
| 2017-03-31 |
18 |
| 2016-12-31 |
14 |
| 2016-09-30 |
15 |
| 2016-06-30 |
14 |
| 2016-03-31 |
11 |
| 2015-12-31 |
7 |
| 2015-09-30 |
7 |
| 2015-06-30 |
5 |
| 2015-03-31 |
|
| 2014-12-31 |
5 |
| 2014-09-30 |
5 |
| 2014-06-30 |
5 |
| 2014-03-31 |
|
| 2013-12-31 |
5 |
| 2013-09-30 |
3 |
| 2013-06-30 |
3 |
| 2013-03-31 |
|
| 2012-12-31 |
3 |
| 2012-09-30 |
3 |
| 2012-06-30 |
3 |
| 2012-03-31 |
|
| 2011-12-31 |
2 |
| 2011-09-30 |
2 |
| 2011-06-30 |
2 |
| 2011-03-31 |
|
| 2010-12-31 |
1 |
| 2010-09-30 |
1 |
| 2010-06-30 |
1 |
| 2010-03-31 |
|
| 2009-12-31 |
1 |
| 2009-09-30 |
0 |
| 2009-06-30 |
0 |
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Transportation |
Transportation - Services |
$0.277B |
$0.228B |
|
CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150? Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.
|
